MUC1 and non-small cell lung carcinoma: Study has elucidated the potent effect of DCs pulsed with WT1 and/or MUC1 peptide vaccines in prolonging survival among patients diagnosed with advanced NSCLC, underscoring their therapeutic potential (284).